Overview


According to FutureWise analysis, the market for Absorbable Tissue Spacer is expected to grow at a CAGR of 10.20% over the forecast period of 2023-2031.

An absorbable tissue spacer refers to a medical device used to create temporary space or separation between tissues during surgical procedures. This typically pertains to substances that are capable of naturally decomposing over a period of time, allowing for gradual absorption by the body. The primary purpose of an absorbable tissue spacer is to provide temporary support, maintain tissue separation, and facilitate the healing process. In some cases, like during orthopedic or plastic surgery, it may be necessary to create space between tissues or organs. This can be necessary for various reasons, including optimizing surgical access, reducing tissue trauma, preventing adhesions, or allowing for proper tissue healing. Absorbable tissue spacers offer a solution by providing a temporary barrier or scaffold that keeps tissues apart while gradually degrading and being absorbed by the body.

Absorbable tissue spacers are fabricated using biocompatible materials like synthetic polymers, collagen, and hyaluronic acid. These carefully chosen materials guarantee their safety within the body, preventing any negative reactions or harm. The choice of material depends on the specific surgical application and desired degradation timeline. One of the key advantages of absorbable tissue spacers is that they eliminate the need for subsequent removal procedures, as they naturally dissolve within the body. This avoids the potential risks and complications associated with the removal of permanent implants. Additionally, absorbable tissue spacers can provide localized drug delivery, allowing for the controlled release of medications or growth factors to enhance the healing process.

FutureWise Market Research has published a report that provides an insightful analysis of Absorbable Tissue Spacer Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Absorbable Tissue Spacer Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Boston Scientific Corporation (Augmenix, Inc.)
  • Palette Life Sciences
  • Bioprotect Ltd.
  • Biocomposites
  • BD (CR Bard)
  • Morita

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Absorbable Tissue Spacer Market:

  • In June 2022, The US FDA has granted approval to Palette Life Sciences' Barrigel, which is a hyaluronic acid rectal spacer. It is a unique product that can provide protection to patients with T1-T3b prostate cancer during their radiation therapy treatment by separating the prostate from the rectum. This is the first and only product of its kind and is a significant development in the field of cancer treatment.

The market for absorbable tissue spacers is experiencing significant growth due to several factors. The increasing global prevalence of cancer serves as a major driving factor for the market. The rising number of cancer diagnoses worldwide has led to an increasing need for precise cancer diagnosis and efficacious treatment options. Absorbable tissue spacers offer advantages in this regard by providing reliable protection and a strong barrier during radiotherapy, which is a common treatment modality for cancer. For example, estimations by the American Cancer Society indicate that the projected count of new cancer cases in the United States is anticipated to reach approximately 1,958,310 by 2023. This growing burden of cancer underscores the need for advanced medical solutions such as absorbable tissue spacers, which can contribute to better outcomes for patients. Moreover, the market's expansion is also fueled by the initiatives taken by key players in the industry. These initiatives include product launches, expansions into new markets, and strategic partnerships. For instance, Palette Life Sciences, a prominent company in the field, has expanded its offerings in Japan and actively pursued regulatory clearance for its Barrigel and Solesta brands. Such efforts not only enhance the availability of absorbable tissue spacers but also drive innovation in the market.

However, there are challenges that hinder the expansion of absorbable tissue spacers market. One significant challenge is the high cost associated with these devices. The expenses involved in manufacturing, R&D, and regulatory compliance contribute to the overall cost, making them less affordable for some patients and healthcare facilities. Additionally, there is a shortage of skilled professionals who can effectively utilize absorbable tissue spacers. Proper training and expertise are essential to ensure the safe and appropriate use of these devices. The shortage of trained professionals limits the widespread adoption and utilization of tissue spacers, thereby impeding the market's expansion.

By Product Type

  • Hydrogel-Based Spacer
  • Biodegradable Hyaluronic Acid Spacer
  • Biodegradable Balloon Spacer
  • Crystal-Based Spacer

By Application

  • Radiotherapy
  • Infection Management

By End-User

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialized Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The absorbable tissue spacer market in North America is anticipated to exhibit significant growth, primarily driven by factors such as the increasing incidence and prevalence of cancers and advancements in cancer treatment technologies. Significantly, the latest statistics provided by the American Cancer Society in January 2023 anticipate an approximate influx of 288,300 cases of prostate cancer and 52,550 fresh cases of colon and rectum cancer in the United States. Additionally, the use of injectable rectal spacers, such as hydrogel spacers, to minimize unintended radiation exposure to the rectum has gained popularity in prostate cancer treatment. Following the FDA approval of SpaceOAR, there has been a surge in referrals for hydrogel placements. These advancements in cancer treatment and the growing demand for innovative solutions are expected to drive the growth of the absorbable tissue spacer market in North America throughout the forecast period.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Absorbable Tissue Spacer By Product Type, By Application, By End-User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Absorbable Tissue Spacer Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Absorbable Tissue Spacer Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Absorbable Tissue Spacer Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Absorbable Tissue Spacer Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hydrogel-Based Spacer
        2. Biodegradable Hyaluronic Acid Spacer
        3. Biodegradable Balloon Spacer
        4. Crystal-Based Spacer

  • 8.   Global Absorbable Tissue Spacer Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Radiotherapy
        2. Infection Management

  • 9.   Global Absorbable Tissue Spacer Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centres
        3. Specialized Clinics

  • 10.   North America Absorbable Tissue Spacer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Absorbable Tissue Spacer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Absorbable Tissue Spacer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Absorbable Tissue Spacer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Absorbable Tissue Spacer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Targeted Antigens Offered and Financial Layouts)
    •   1. Boston Scientific Corporation (Augmenix, Inc.)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Palette Life Sciences
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bioprotect Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Biocomposites
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BD (CR Bard)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Morita
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients